167 related articles for article (PubMed ID: 32037002)
1. Role of imaging biomarkers for prognostic prediction in patients with pancreatic ductal adenocarcinoma.
Cui SJ; Tang TY; Zou XW; Su QM; Feng L; Gong XY
Clin Radiol; 2020 Jun; 75(6):478.e1-478.e11. PubMed ID: 32037002
[TBL] [Abstract][Full Text] [Related]
2. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
[TBL] [Abstract][Full Text] [Related]
3. Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease.
Soloff EV; Zaheer A; Meier J; Zins M; Tamm EP
Abdom Radiol (NY); 2018 Feb; 43(2):301-313. PubMed ID: 29198002
[TBL] [Abstract][Full Text] [Related]
4. Molecular radionuclide imaging of pancreatic neoplasms.
Panda A; Garg I; Johnson GB; Truty MJ; Halfdanarson TR; Goenka AH
Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):559-570. PubMed ID: 31169124
[TBL] [Abstract][Full Text] [Related]
5. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
[TBL] [Abstract][Full Text] [Related]
6. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.
Nahm CB; Turchini J; Jamieson N; Moon E; Sioson L; Itchins M; Arena J; Colvin E; Howell VM; Pavlakis N; Clarke S; Samra JS; Gill AJ; Mittal A
Eur J Surg Oncol; 2019 Feb; 45(2):218-224. PubMed ID: 30348604
[TBL] [Abstract][Full Text] [Related]
7. Patient-Friendly Summary of the ACR Appropriateness Criteria: Staging of Pancreatic Ductal Adenocarcinoma.
Rybicki FJ; Lalani T
J Am Coll Radiol; 2019 Apr; 16(4 Pt A):e15. PubMed ID: 30947954
[No Abstract] [Full Text] [Related]
8. Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.
Esposito I; Konukiewitz B; Schlitter AM; Klöppel G
World J Gastroenterol; 2014 Oct; 20(38):13833-41. PubMed ID: 25320520
[TBL] [Abstract][Full Text] [Related]
9. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.
Bowman AW; Bolan CW
Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy.
Song KB; Kwon J; Kim YW; Hwang DW; Lee JH; Hong S; Lee JW; Hwang K; Yoo D; Kim SC
J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):227-234. PubMed ID: 30980486
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma.
Karabicak I; Satoi S; Yanagimoto H; Yamamoto T; Hirooka S; Yamaki S; Kosaka H; Inoue K; Matsui Y; Kon M
J Hepatobiliary Pancreat Sci; 2016 Dec; 23(12):750-755. PubMed ID: 27794194
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of collagen signatures in pancreatic ductal adenocarcinoma obtained from second-harmonic generation imaging.
Chen X; Chen L; Miao J; Huang X; Han X; Zheng L; Xu S; Chen J; Li L
BMC Cancer; 2024 May; 24(1):652. PubMed ID: 38811917
[TBL] [Abstract][Full Text] [Related]
13. Response assessment in pancreatic ductal adenocarcinoma: role of imaging.
Baliyan V; Kordbacheh H; Parakh A; Kambadakone A
Abdom Radiol (NY); 2018 Feb; 43(2):435-444. PubMed ID: 29243123
[TBL] [Abstract][Full Text] [Related]
14. Resectable pancreatic adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes.
Cassinotto C; Chong J; Zogopoulos G; Reinhold C; Chiche L; Lafourcade JP; Cuggia A; Terrebonne E; Dohan A; Gallix B
Eur J Radiol; 2017 May; 90():152-158. PubMed ID: 28583627
[TBL] [Abstract][Full Text] [Related]
15. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the diagnostic and prognostic value of long non-coding RNA SNHG15 in pancreatic ductal adenocarcinoma.
Guo XB; Yin HS; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5892-5898. PubMed ID: 30280769
[TBL] [Abstract][Full Text] [Related]
17. The role of imaging in the clinical practice of radiation oncology for pancreatic cancer.
Koay EJ; Hall W; Park PC; Erickson B; Herman JM
Abdom Radiol (NY); 2018 Feb; 43(2):393-403. PubMed ID: 29110053
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Ductal Adenocarcinoma and Its Variants: Pearls and Perils.
Schawkat K; Manning MA; Glickman JN; Mortele KJ
Radiographics; 2020; 40(5):1219-1239. PubMed ID: 32678699
[TBL] [Abstract][Full Text] [Related]
20. Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future.
Barhli A; Cros J; Bartholin L; Neuzillet C
Dig Liver Dis; 2018 Oct; 50(10):979-990. PubMed ID: 30205952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
